Deregulation of tumor angiogenesis and blockade of tumor growth in PPARbeta-deficient mice

EMBO J. 2007 Aug 8;26(15):3686-98. doi: 10.1038/sj.emboj.7601803. Epub 2007 Jul 19.

Abstract

The peroxisome proliferator-activated receptor-beta (PPARbeta) has been implicated in tumorigenesis, but its precise role remains unclear. Here, we show that the growth of syngeneic Pparb wild-type tumors is impaired in Pparb(-/-) mice, concomitant with a diminished blood flow and an abundance of hyperplastic microvascular structures. Matrigel plugs containing pro-angiogenic growth factors harbor increased numbers of morphologically immature, proliferating endothelial cells in Pparb(-/-) mice, and retroviral transduction of Pparb triggers microvessel maturation. We have identified the Cdkn1c gene encoding the cell cycle inhibitor p57(Kip2) as a PPARbeta target gene and a mediator of the PPARbeta-mediated inhibition of cell proliferation, which provides a possible mechanistic explanation for the observed tumor endothelial hyperplasia and deregulation of tumor angiogenesis in Pparb(-/-) mice. Our data point to an unexpected essential role for PPARbeta in constraining tumor endothelial cell proliferation to allow for the formation of functional tumor microvessels.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • Cyclin-Dependent Kinase Inhibitor p57 / metabolism
  • Down-Regulation*
  • Endothelium, Vascular / pathology
  • Magnetic Resonance Imaging
  • Mice
  • Mice, Knockout
  • Neoplasms, Experimental / blood supply*
  • Neoplasms, Experimental / pathology
  • Neovascularization, Pathologic*
  • Oligonucleotide Array Sequence Analysis
  • PPAR-beta / genetics
  • PPAR-beta / metabolism
  • PPAR-beta / physiology*

Substances

  • Cdkn1c protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p57
  • PPAR-beta